Stocks · NASDAQ · Healthcare · United States
VRTX — Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc (VRTX) is a healthcare stock listed on NASDAQ (United States). At the close of September 29, 2026 it traded at 526.73 (-0.18% on the day), -3.3% over one month, +5.8% over three months, +33.2% over twelve months. The InvestMuse composite score is +83 on a −100 to +100 scale, a strong bullish read that ranks #23 of about 1,221 assets. The strongest of its nine dimensions are Fundamentals (+77) and Sector edge (+63); the weakest is Technical indicators (-26). Its volatility regime from the hidden Markov model is Hot. 55 news articles in the last 30 days carried an average tone of +0.29 (on −1 to +1).
The facts
| Last close | 526.73 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -0.18% / -3.3% / +5.8% / +33.2% |
| 52-week range | 391.64 – 557.96 |
| Composite score | +83 / 100 · strong bullish view · rank #23 |
| Volatility regime (HMM) | Hot |
| Resistance levels | 200.00, 465.00 |
| Trailing P/E | 28.8 |
| Market cap | $127.0B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)+60
- Technical indicators-26
- Trend+32
- Support / resistance0
- Fundamentals+77
- Sector edge+63
- News sentiment+31
- Momentum+9
- Chart patterns and zones+40
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.